{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:06:17Z","timestamp":1789628777305,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["arthroplastyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Arthroplasty"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.arth.2025.12.041","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T08:01:26Z","timestamp":1767168086000},"page":"2985-2991.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Aspirin May Be a Suitable Prophylaxis for Cancer Patients Undergoing Primary Total Knee Arthroplasty"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3866-4657","authenticated-orcid":false,"given":"Saad","family":"Tarabichi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens T.","family":"Verhey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Collin","family":"Braithwaite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rigel P.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Lebens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary K.","family":"Christopher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Spangehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua S.","family":"Bingham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arth.2025.12.041_bib1","first-page":"1487","article-title":"Prevalence of primary and revision total hip and knee arthroplasty in the United States from 1990 through 2002","volume":"87","author":"Kurtz","year":"2005","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2025.12.041_bib2","doi-asserted-by":"crossref","first-page":"780","DOI":"10.2106\/00004623-200704000-00012","article-title":"Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030","volume":"89","author":"Kurtz","year":"2007","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2025.12.041_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.arth.2009.07.021","article-title":"Venous thromboembolism","volume":"25","author":"Markel","year":"2010","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.12.041_bib4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2106\/JBJS.21.01531","article-title":"Recommendations from the ICM-VTE: general","volume":"104","year":"2022","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2025.12.041_bib5","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.arth.2016.03.031","article-title":"Aspirin can be used as prophylaxis for prevention of venous thromboembolism after revision hip and knee arthroplasty","volume":"31","author":"Deirmengian","year":"2016","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.12.041_bib6","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.arth.2021.10.001","article-title":"Aspirin thromboprophylaxis is associated with less major bleeding events following total joint arthroplasty","volume":"37","author":"Shohat","year":"2022","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.12.041_bib7","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2106\/JBJS.16.00147","article-title":"Low-Dose aspirin is effective chemoprophylaxis against clinically important venous thromboembolism following total joint arthroplasty","volume":"99","author":"Parvizi","year":"2017","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2025.12.041_bib8","doi-asserted-by":"crossref","first-page":"504","DOI":"10.2106\/JBJS.18.00143","article-title":"The use of aspirin for prophylaxis against venous thromboembolism decreases mortality following primary total joint arthroplasty","volume":"101","author":"Rondon","year":"2019","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2025.12.041_bib9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.arth.2015.07.001","article-title":"Administration of aspirin as a prophylaxis agent against venous thromboembolism results in lower incidence of periprosthetic joint infection","volume":"30","author":"Huang","year":"2015","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.12.041_bib10","doi-asserted-by":"crossref","first-page":"180","DOI":"10.2106\/JBJS.21.01529","article-title":"Recommendations from the ICM-VTE: hip & Knee","volume":"104","year":"2022","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2025.12.041_bib11","doi-asserted-by":"crossref","first-page":"768","DOI":"10.5435\/00124635-201112000-00007","article-title":"Preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty","volume":"19","author":"Mont","year":"2011","journal-title":"Am Acad Orthop Surg"},{"key":"10.1016\/j.arth.2025.12.041_bib12","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1055\/s-0035-1564040","article-title":"Cancer tissue procoagulant mechanisms and the hypercoagulable State of patients with cancer","volume":"41","author":"Falanga","year":"2015","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.arth.2025.12.041_bib13","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.2106\/JBJS.F.00235","article-title":"Multimodal thromboprophylaxis for total hip and knee arthroplasty based on risk assessment","volume":"89","author":"Dorr","year":"2007","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2025.12.041_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12891-015-0470-0","article-title":"Risk factors for venous thromboembolism of total hip arthroplasty and total knee arthroplasty: a systematic review of evidences in ten years","volume":"16","author":"Zhang","year":"2015","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.arth.2025.12.041_bib15","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1007\/s00264-008-0659-z","article-title":"Risk factors for pulmonary embolism after hip and knee arthroplasty: a population-based study","volume":"33","author":"Memtsoudis","year":"2009","journal-title":"Int Orthop (SICOT)"},{"key":"10.1016\/j.arth.2025.12.041_bib16","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.arth.2014.12.017","article-title":"Total joint arthroplasty in cancer patients","volume":"30","author":"Karam","year":"2015","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.12.041_bib17","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0140-6736(20)32658-1","article-title":"Venous thromboembolism","volume":"398","author":"Khan","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.arth.2025.12.041_bib18","doi-asserted-by":"crossref","first-page":"232","DOI":"10.2106\/JBJS.21.01108","article-title":"Recommendations from the ICM-VTE: oncology","volume":"104","year":"2022","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2025.12.041_bib19","doi-asserted-by":"crossref","first-page":"589","DOI":"10.2106\/JBJS.18.00335","article-title":"Potent anticoagulation does not reduce venous thromboembolism in high-risk patients","volume":"101","author":"Tan","year":"2019","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2025.12.041_bib20","doi-asserted-by":"crossref","first-page":"e278S","DOI":"10.1378\/chest.11-2404","article-title":"Prevention of VTE in orthopedic surgery patients","volume":"141","author":"Falck-Ytter","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.arth.2025.12.041_bib21","unstructured":"fy-2025-icd-10-cm-coding-guidelines.pdf n.d."},{"key":"10.1016\/j.arth.2025.12.041_bib22","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1016\/j.arth.2024.05.050","article-title":"Aspirin as venous thromboembolism prophylaxis in arthroplasty patients: an Analysis of Clinical Practice Guidelines recommendations","volume":"39","author":"Lun","year":"2024","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.12.041_bib23","doi-asserted-by":"crossref","first-page":"S328","DOI":"10.1016\/j.arth.2024.01.050","article-title":"Trends in deep vein thrombosis prophylaxis after total knee arthroplasty: 2016 to 2021","volume":"39","author":"Dubin","year":"2024","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.12.041_bib24","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.2106\/JBJS.23.01158","article-title":"Low-Dose aspirin is the safest prophylaxis for prevention of venous thromboembolism after total knee arthroplasty across all patient risk profiles","volume":"106","author":"Lavu","year":"2024","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2025.12.041_bib25","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1016\/j.arth.2020.07.004","article-title":"Persistent wound drainage among total joint arthroplasty patients receiving aspirin vs coumadin","volume":"35","author":"Singh","year":"2020","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.12.041_bib26","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.2106\/JBJS.21.00601","article-title":"Aspirin May be a suitable prophylaxis for patients with a history of venous thromboembolism undergoing total joint arthroplasty","volume":"104","author":"Ludwick","year":"2022","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2025.12.041_bib27","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.2106\/JBJS.22.01024","article-title":"Low-Molecular-Weight heparin is superior to aspirin in the prevention of thromboembolic disease: or is it?","volume":"104","author":"Parvizi","year":"2022","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2025.12.041_bib28","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1161\/01.STR.27.4.585","article-title":"Aspirin wars","volume":"27","author":"Hart","year":"1996","journal-title":"Stroke"},{"key":"10.1016\/j.arth.2025.12.041_bib29","doi-asserted-by":"crossref","first-page":"e89S","DOI":"10.1378\/chest.11-2293","article-title":"Antiplatelet drugs","volume":"141","author":"Eikelboom","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.arth.2025.12.041_bib30","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0140-6736(00)02110-3","article-title":"Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial","volume":"355","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.arth.2025.12.041_bib31","article-title":"Which medications are effective in reducing the risk of arthrofibrosis after total knee arthroplasty?","author":"Hall","year":"2025","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.12.041_bib32","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1016\/j.arth.2024.05.079","article-title":"Decreased risk of readmission and complications with preoperative GLP-1 analog use in patients undergoing primary total joint arthroplasty","volume":"39","author":"Buddhiraju","year":"2024","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.12.041_bib33","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.5435\/JAAOS-D-24-01284","article-title":"The effects of glucagon-like Peptide-1 agonist therapy on risk of infection, fracture, and early revision in primary total joint arthroplasty","volume":"33","author":"Levidy","year":"2025","journal-title":"J Am Acad Orthop Surg"},{"key":"10.1016\/j.arth.2025.12.041_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.artd.2024.101359","article-title":"Comparison of postoperative outcomes of patients undergoing total hip and total knee arthroplasty following a diagnosis of dementia: a TriNetX database study","volume":"27","author":"Johnson","year":"2024","journal-title":"Arthroplast Today"},{"key":"10.1016\/j.arth.2025.12.041_bib35","article-title":"Low-Dose aspirin: the safest prophylactic approach for venous thromboembolism prevention following total hip arthroplasty across all risk profiles","author":"Porto","year":"2025","journal-title":"J Arthroplasty"}],"container-title":["The Journal of Arthroplasty"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883540325016146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883540325016146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:43:31Z","timestamp":1789627411000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883540325016146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0883540325016146"],"URL":"https:\/\/doi.org\/10.1016\/j.arth.2025.12.041","relation":{},"ISSN":["0883-5403"],"issn-type":[{"value":"0883-5403","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aspirin May Be a Suitable Prophylaxis for Cancer Patients Undergoing Primary Total Knee Arthroplasty","name":"articletitle","label":"Article Title"},{"value":"The Journal of Arthroplasty","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arth.2025.12.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}